A prospective randomised trial of cyclosporin versus methotrexate after HLA-identical sibling marrow transplantation for patients with acute leukemia in first remission: analysis 2.5 years after last patient entry.
暂无分享,去创建一个
J. Biggs | K. Atkinson | A. Dodds | A. Concannon | M. Ashby | K. Downs
[1] K. Atkinson,et al. Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty. , 1987, Bone marrow transplantation.
[2] K. Atkinson,et al. Late onset transfusion-dependent anaemia with thrombocytopenia secondary to marrow fibrosis and hypoplasia associated with chronic graft-versus-host disease. , 1987, Bone marrow transplantation.
[3] J. Biggs,et al. The development of the acquired immunodeficiency syndrome after bone-marrow transplantation. , 1987, The Medical journal of Australia.
[4] J. Biggs,et al. A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy. , 1987, Australian and New Zealand journal of medicine.
[5] J. Biggs,et al. The impact of leukemia status at the time of HLA-identical sibling marrow transplantation on subsequent complication rate and survival of adults with acute leukemia. , 1986, Australian and New Zealand journal of medicine.
[6] R. Marcus,et al. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. , 1986, Bone marrow transplantation.
[7] G. Gahrton,et al. A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies. , 1986, Bone marrow transplantation.
[8] J. Biggs,et al. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation. , 1986, Transplantation proceedings.
[9] Kennedy,et al. Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. , 1985, Blood.
[10] Kennedy,et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. , 1985, Blood.
[11] P. Neiman,et al. Donor cell leukemia developing six years after marrow grafting for acute leukemia. , 1985, Blood.
[12] H. Deeg,et al. Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine. , 1985, Leukemia research.
[13] J. Hermans,et al. Bone marrow transplantation for acute lymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) , 1984, British journal of haematology.
[14] K. Lafferty,et al. Inhibition of T‐Cell Activity by Cyclosporin A , 1982, Scandinavian journal of immunology.
[15] K. Sullivan,et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. , 1981, Blood.
[16] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.
[17] P. Neiman,et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.
[18] R. Storb,et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. , 1974, Transplantation proceedings.
[19] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[20] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .